Crispr has been making waves with its success in fighting rare genetic diseases, but could it also help turn bacterium’s machinery against itself? In the era of superbugs, scientists are hopeful the technology can be a game-changer. Meanwhile, GSK has announced a late-stage study for its new antibiotic to fight urinary tract infections and gonorrhoea.
from Kaiser Health News https://ift.tt/2ow3hgU
October 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
House Majority Leader Presses Lawmakers To Move Ahead With Solution For Surprise Medical BillsSo far the legislation has hit road bumps despite the bipartisan interest in addressing an issue that voters care about. House Majority Leader Steny Hoyer (D-Md.) wants lawmakers to come up with a deal. In other health indust… Read More
Better TB Vaccines Needed?: Strength Can Vary Greatly From One Manufacturer To The Next.Researchers from around the world are questioning whether some vaccines are more protective than others and if a new costly trial would be worthwhile. But it would be costly. Public health news is on cystic fibrosis, improvin… Read More
CMS To Invite States To Apply For Waivers To Transform Medicaid Programs Into Block Grant ModelThe letters to state officials are expected to go out on Thursday. Proponents and critics alike expect any changes to face legal challenges. Allowing block grants in Medicaid has been a prime objective for CMS Administrator S… Read More
FDA Warns Purell To Stop Claiming Hand Sanitizers Can Prevent Flu, EbolaThe agency doesn't allow brands to make such claims. The CDC recommends washing hands with soap and water as the most effective way to prevent spread of germs and to use a hand sanitizer that is 60% ethyl alcohol when they're… Read More
States Grapple With Emerging Threat Of Coronavirus As They Prepare For More Possible CasesNews stories from across the country look at where patients are being monitored over concerns of infections. from Kaiser Health News https://ift.tt/37BdPfP … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment